Assessing I-SABR in early or recurrent non-small cell lung cancer



Joe Chang, MD, PhD, The University of Texas MD Anderson Cancer Centre, Houston, TX, shares the results of the Phase II trial …

source

Leave a Reply

Your email address will not be published. Required fields are marked *

Amazon Affiliate Disclaimer

Amazon Affiliate Disclaimer

“As an Amazon Associate I earn from qualifying purchases.”

Learn more about the Amazon Affiliate Program